| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price |
|---|---|---|---|---|---|---|---|---|
| MICB | Human MICB Protein, His Tag (MALS verified) | Human | HEK293 | ![]() | MALSSDS-PAGE | $395.00 100ug |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Isuventatug | CLN-619 | Phase 1 Clinical | Cullinan MICA Corp | Carcinoma, Non-Small-Cell Lung; Multiple Myeloma; Solid tumours | Details |
| FT-536 | FT-536 | Phase 1 Clinical | Fate Therapeutics Inc | Abdominal Neoplasms; Fallopian Tube Neoplasms; Genital Neoplasms, Female; Ovarian Neoplasms; Solid tumours | Details |
| FT-836 | FT-836; FT836 | Phase 1 Clinical | Fate Therapeutics Inc | Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Endometrial Neoplasms; Neoplasms; Ovarian Neoplasms; Squamous Cell Carcinoma of Head and Neck | Details |
| DM-919 | DM-919; DM919 | Phase 1 Clinical | D2M Biotherapeutics Inc | Neoplasms; Solid tumours | Details |